2025
SJR Q2
JCR Q2 · 3,3
OA
3 matched articles
SCIE
Journal detail
Therapeutic Advances in Drug Safety
- Publisher
- SAGE Publications Ltd
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
2042098620420994
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,833
- Quartile Q2
- H-Index 55
- Cites/doc 2,96
- Docs (3y) 110
- Cites (3y) 366
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 3,3
- 5Y JIF 4,2
- JCI 0,75
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Pharmacology (medical) Q2
Areas
- Medicine
WoS categories
- Pharmacology & Pharmacy
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,833 | 3,3 | 4,2 | 0,75 | Q2 | 55 |
| 2024 | Q1 | Q2 | 1,165 | 3,4 | 4 | 0,73 | Q2 | 51 |
| 2023 | Q1 | Q2 | 1,035 | 3,4 | 4 | 0,72 | Q2 | 51 |
| 2022 | Q2 | Q2 | 0,715 | 4,4 | 4,2 | 0,59 | Q3 | 51 |
| 2021 | Q2 | Q3 | 0,837 | 3,2 | 4,2 | 0,59 | Q3 | 51 |
| 2020 | Q1 | Q2 | 1,196 | 3,8 | 4,4 | 0,69 | Q2 | 51 |
| 2019 | Q1 | Q2 | 1,072 | 3,5 | — | 0,74 | Q2 | 51 |
| 2017 | Q1 | — | 1,494 | — | — | — | — | 51 |
| 2016 | Q1 | — | 1,702 | — | — | — | — | 51 |
| 2015 | Q1 | — | 1,451 | — | — | — | — | 51 |
| 2014 | Q3 | — | 0,36 | — | — | — | — | 51 |
| 2013 | Q2 | — | 0,399 | — | — | — | — | 51 |
| 2012 | Q3 | — | 0,209 | — | — | — | — | 51 |
| 2011 | Q4 | — | 0,105 | — | — | — | — | 51 |
| 2010 | — | — | — | — | — | — | — | 51 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 149/356 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 113/352 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 105/354 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q3 | 81/278 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 165/279 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 120/276 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 86/271 |